Please login to the form below

Not currently logged in
Email:
Password:

Sting agonists

This page shows the latest Sting agonists news and features for those working in and with pharma, biotech and healthcare.

Bayer signs €250m pact with India’s Curadev for STING drugs

Bayer signs €250m pact with India’s Curadev for STING drugs

More than a dozen biopharma companies have been looking at STING agonists as potential treatments for cancer by switching on the inflammatory response against tumour cells, including Merck &Co and Novartis. ... There’s still interest in STING agonists,

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    There are various companies working on toll-like receptor agonists that stimulate antigen-presenting cells, such as Idera’s TLR9-targeted drug IMO-2125 which boosted the activity of BMS’ CTLA4 ... Among the plethora in the pipeline, Aurigene and BMS

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...